Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.49% · OPTIONAL
· Biological Products, (No Diagnostic Substances)
RESEARCH SNAPSHOTVericel Corp's latest supported as-filed period reports revenue of $77.5M; gross margin moved 89 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 2.49% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 20.90% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 22.48% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 23.73% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 72.82% · CORE
Level · gp.fundamentals.operating_margin
Raw value 0.56% · CORE
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +55.7% from the comparable as-filed period.
Gross margin changed -89 basis points from the comparable as-filed period.
Gross profit changed +21.0% from the comparable as-filed period.
Inventory changed +9.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
VCEL · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001140361-26-033143SEC ↗4Aug 5, 2026Period Aug 3, 20260001140361-26-031417SEC ↗4Jul 31, 2026Period Jul 30, 20260001140361-26-030487SEC ↗10-QJul 30, 2026Period Jun 30, 20260001628280-26-050836SEC ↗8-KJul 30, 2026Period Jul 30, 20260001628280-26-050815SEC ↗4Jun 30, 2026Period Jun 26, 20260001140361-26-026932SEC ↗4Jun 30, 2026Period Jun 26, 20260001140361-26-026931SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Aug 12, 2026Filed Aug 14, 2026 | MCLAUGHLIN KEVIN FDirector | Option ExerciseDirect | 7,000 | $13 | $91,350 | Form 4 ↗ |
| Aug 12, 2026Filed Aug 14, 2026 | MCLAUGHLIN KEVIN FDirector | Open Market SaleDirect | 7,000 | $45 | $311,710 | Form 4 ↗ |
| Aug 12, 2026Filed Aug 14, 2026 | MCLAUGHLIN KEVIN FDirector | Option ExerciseDirect | 7,000 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 9.67% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 11.73% · OPTIONAL
Net income changed +498.9% from the comparable as-filed period.
Operating income changed +121.4% from the comparable as-filed period.
Operating margin changed +377 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001140361-26-026930